By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    healthcare cybersecurity
    4 Helpful Tips on How to Protect Your Medical Practice Against Cyber Attacks
    October 24, 2021
    Health Check Diagnosis Medical Condition Analysis Concept
    6 Health Woes With Online Remedies
    January 19, 2022
    Eight Things Men Should Know About the Male Menopause
    Eight Things Men Should Know About the Male Menopause
    April 24, 2022
    Latest News
    Getting Back in the Game: Sports Injuries Rehabilitation Tips
    May 31, 2023
    4 Signs It’s Time to See a Therapist
    May 24, 2023
    11 Ways To Modernize Your Private Practice
    May 17, 2023
    How to Recognize the Signs of Hormonal Imbalance in Men
    May 29, 2023
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    What Will a Whole Foods Health Clinic Look Like?
    February 9, 2015
    Driving Down the Real Cost of Healthcare: Pediatric and Teen Medical Homes
    November 11, 2012
    Why Clinicians Need to Embrace Their HIT Teams
    January 25, 2016
    Latest News
    MRI Sedation Options: What You Should Know Before Screening
    May 17, 2023
    What is the Process of Creating Medicine from Nature?
    May 2, 2023
    Choosing the Right Treatment Option for Varicose Veins
    May 2, 2023
    What Are Wrong-Site Surgeries and How Do They Occur?
    April 27, 2023
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: MIGS Device Approval Brings Hope For Glaucoma Patients
Share
Sign In
Notification Show More
Aa
Health Works CollectiveHealth Works Collective
Aa
Search
Have an existing account? Sign In
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Devices > MIGS Device Approval Brings Hope For Glaucoma Patients
Medical DevicesMedical InnovationsTechnology

MIGS Device Approval Brings Hope For Glaucoma Patients

Satyajit Shinde
Last updated: 2018/08/21 at 7:42 PM
Satyajit Shinde
Share
6 Min Read
MIGS-devices-market
SHARE

 

The U.S. FDA has already approved Ivantis’s Hydrus Microstent and Allergan’s XEN Gel Stent for minimally invasive glaucoma surgery. With ongoing research activities, there will be more approvals in the future to help glaucoma patients.

The World Health Organization (WHO) survey states that glaucoma is the second highest cause of blindness in the world. Many people have this condition, but unaware of it. The symptoms are not evident until the patient loses his sight. Judith Smith, a nurse by profession, showed the signs of glaucoma during her regular visit to the ophthalmologist a few years ago. Even though glaucoma is a permanent condition, the available treatment can slow down the progression. There are eye drops available which can either increase or decrease the quantity of fluid in the eye or enhance the outward flow. This reduces the eye pressure and safeguards the optic nerve from damage. However, some patients do not respond well to them and show negative effects. Smith was one of them.

Then she met Robert Feldman, M.D., Chair of the Ruiz Department of Ophthalmology and Visual Science at McGovern Medical School at UTHealth, at her workplace. He was conducting a clinical trial to determine the efficacy of a minimally-invasive glaucoma surgery that used the InnFocus MicroShunt Glaucoma Drainage System. The study also aimed to compare the new system with a traditional trabeculectomy. Smith participated in the study.

More Read

healthcare cybersecurity

3 Pressing Healthcare Cyber Security Challenges and How to Address Them

Cutting-Edge Medical Innovations Are Disrupting Healthcare
Top 10 Reasons to Improve Medical Website Accessibility
The Top 5 Considerations for Successful Medical Device Software Development
The Vital Role of Medical Interpreting Services In Healthcare

The procedure in the study involved creating a small incision in the eye through which a MicroShunt will be inserted. This MicroShunt is the twice the size of an eyelash. It allows fluid to drain from the anterior chamber to the conjunctival flap of the eye. Researchers have used this procedure on 30 times during the past three years. Many of the participants have shown great outcomes. This procedure reduces recovery time and eliminates the need for surgery. The InnFocus MicroShunt procedure slows down the progression of glaucoma.

There have been many trials performed by research institutes and organizations to find minimally invasive devices for glaucoma surgery. The U.S. Food and Drug Administration (FDA) approved many of the stents for treatment of patients with glaucoma. Ivantis, a company aimed for development of innovative solutions for glaucoma, received FDA approval for Hydrus® Microstent. It is a minimally invasive glaucoma surgery (MIGS) device that can be utilized for the treatment of mild to moderate open-angle glaucoma in collaboration with cataract surgery.

David F. Chang, M.D., clinical professor of Ophthalmology at the University of California, San Francisco, said, “The Hydrus Microstent scaffolds approximately 90 degrees of the patient’s natural canal outflow pathway. Correct anatomic placement into the canal will also be easier for surgeons to confirm.”

The clinical data regarding Hydrus shows its safety and two-year efficacy along with its ability to eliminate medications. The eyelash-sized device lowers the eye pressure through maintenance of flow through Schlemm’s canal, the eye’s natural outflow pathway. It has been used in nearly 4,000 procedures across the globe. Ivantis is now planning to build the commercial and manufacturing infrastructures along with the launch of the product in late 2018.

In November 2016, the FDA also approved XEN Gel Stent by Allergan. This device can be used in MIGS procedures combined with cataract surgery to enable a two-in-one procedure. It will reduce IOP through drainage of aqueous humor into the subconjunctival space. It avoids the use of the traditional pathways such as the uveoscleral pathway or the trabecular meshwork.

The Xen Glaucoma Treatment System has the Xen 45 gel stent along with the disposable Xen injector. The 6 mm gel stent has gelatin cross-linked with glutaraldehyde, which is stiff but gets flexible when hydrated using the aqueous humor. This hydration makes the gel secure from erosion or fibrosis. The cross-linking prevents the degradation of the stent over time. These factors ensure a stable structure of the gel stent to circulate the aqueous humor appropriately. The stent is inserted through a corneal incision using the Xen injector. Then gel stent reduces IOP by letting the aqueous humor drain through the subconjunctival space. This is a minimally invasive approach.

The trend of FDA approval will continue with ongoing research and development activities, it will take the MIGS devices market to great heights. According to the research firm Allied Market Research, the global minimally invasive glaucoma surgery (MIGS) devices market would reach $912 million by 2023. Owing to long-term IOP control and the ability of clinicians to intervene in earlier stages of glaucoma lifecycle, the demand for MIGS devices is increasing. In a discussion with Primary Care Optometry News, John Berdahl, MD, said the benefits of micro-invasive glaucoma surgery (MIGS) have been overwhelming and offer safety. “Surgeons across the U.S. are flocking to these procedures,” he added. “With MIGS, we can lower eye pressure without patients having to take medication, or we can reduce the number of medications they need while still not subjecting them to the risks of traditional glaucoma surgery.”

TAGGED: glaucoma, migs devices, migs devices market

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Satyajit Shinde August 21, 2018
Share this Article
Facebook Twitter Copy Link Print
Share
By Satyajit Shinde
Follow:
Satyajit has always had a keen interest in reading and writing. He forayed into the field of writing due to his love for words and the urge to do something different. He aspires to make each of his written works a piece of art.
Previous Article 6 Questions To Ask When Choosing The ‘Right’ Kind Of Care For Seniors
Next Article 5 Easy Tips To Help Your Kids And Teens Eat Healthy

Stay Connected

1.5k Followers Like
4.5k Followers Follow
2.8k Followers Pin
136k Subscribers Subscribe

Latest News

medical bills
Who is Responsible for Paying the Medical Bills After an Injury?
News June 1, 2023
sports injury rehabilitation
Getting Back in the Game: Sports Injuries Rehabilitation Tips
Health May 31, 2023
brush your day
How Many Times A Day Should You Brush Your Teeth?
Dental health May 29, 2023
Chiropractic Laser Therapy: A Beacon of Hope for Chronic Pain Sufferers
Chiropractic Laser Therapy: A Beacon of Hope for Chronic Pain Sufferers
Therapies May 29, 2023

You Might also Like

medical answering service
Technology

How Medical Answering Services Can Improve Patient Care

May 25, 2023
pet health apps
News

9 Best Apps for Pet Owners Trying to Keep their Animals Healthy

May 22, 2023
Biotechnology
Technology

What Are The Benefits of Biotechnology?

May 17, 2023
CRM for pharmaceutical
Technology

The Top Benefits of CRM Tools for Pharmaceutical Brands

May 11, 2023
//

We influence million of users and is the most authentic source of information on healthcare business and technology news.

Quick Links

  • About
  • Contact
  • Privacy
Subscribe

Subscribe to our newsletter to get our newest articles instantly!

Follow US

© 2008-2023 HealthWorks Collective. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?